vs
维珍大西洋航空（ATLN）与GE医疗（CCRN）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是维珍大西洋航空的2.0倍（$236.8M vs $120.0M）。维珍大西洋航空净利率更高（-22.6% vs -35.0%，领先12.4%）。维珍大西洋航空同比增速更快（-7.3% vs -23.6%）。GE医疗自由现金流更多（$16.1M vs $-8.2M）。过去两年维珍大西洋航空的营收复合增速更高（9.2% vs -21.0%）
维珍大西洋航空（简称维珍航空）是英国知名航空公司，总部位于英格兰西萨塞克斯郡克劳利。该公司成立于1984年，最初名为不列颠大西洋航空，创始人原本计划开通伦敦至福克兰群岛的航线，更名后创始人之一将股份售予理查德·布兰森，如今是英国航空市场的核心运营商之一。
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
ATLN vs CCRN — 直观对比
营收规模更大
CCRN
是对方的2.0倍
$120.0M
营收增速更快
ATLN
高出16.3%
-23.6%
净利率更高
ATLN
高出12.4%
-35.0%
自由现金流更多
CCRN
多$24.3M
$-8.2M
两年增速更快
ATLN
近两年复合增速
-21.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $120.0M | $236.8M |
| 净利润 | $-27.1M | $-82.9M |
| 毛利率 | 9.1% | — |
| 营业利润率 | -19.5% | -30.2% |
| 净利率 | -22.6% | -35.0% |
| 营收同比 | -7.3% | -23.6% |
| 净利润同比 | 60.5% | -2109.7% |
| 每股收益（稀释后） | $-0.48 | $-2.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATLNCCRN
| Q4 25 | $120.0M | $236.8M | ||
| Q3 25 | $110.1M | $250.1M | ||
| Q2 25 | $102.9M | $274.1M | ||
| Q1 25 | $102.8M | $293.4M | ||
| Q4 24 | $129.5M | $309.9M | ||
| Q3 24 | $107.8M | $315.1M | ||
| Q2 24 | $104.6M | $339.8M | ||
| Q1 24 | $100.6M | $379.2M |
净利润ATLNCCRN
| Q4 25 | $-27.1M | $-82.9M | ||
| Q3 25 | $-10.8M | $-4.8M | ||
| Q2 25 | $-10.7M | $-6.7M | ||
| Q1 25 | $-10.7M | $-490.0K | ||
| Q4 24 | $-68.7M | $-3.8M | ||
| Q3 24 | $-7.0M | $2.6M | ||
| Q2 24 | $-54.9M | $-16.1M | ||
| Q1 24 | $-4.9M | $2.7M |
毛利率ATLNCCRN
| Q4 25 | 9.1% | — | ||
| Q3 25 | 11.3% | 20.4% | ||
| Q2 25 | 11.1% | 20.4% | ||
| Q1 25 | 10.9% | 20.0% | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 11.0% | 20.4% | ||
| Q2 24 | 11.0% | 20.8% | ||
| Q1 24 | 10.4% | 20.4% |
营业利润率ATLNCCRN
| Q4 25 | -19.5% | -30.2% | ||
| Q3 25 | -7.9% | -2.4% | ||
| Q2 25 | -8.4% | -2.1% | ||
| Q1 25 | -9.2% | -0.3% | ||
| Q4 24 | -4.5% | -1.1% | ||
| Q3 24 | -6.0% | 0.9% | ||
| Q2 24 | -7.9% | -5.7% | ||
| Q1 24 | -1.1% | 0.8% |
净利率ATLNCCRN
| Q4 25 | -22.6% | -35.0% | ||
| Q3 25 | -9.8% | -1.9% | ||
| Q2 25 | -10.4% | -2.4% | ||
| Q1 25 | -10.5% | -0.2% | ||
| Q4 24 | -53.0% | -1.2% | ||
| Q3 24 | -6.5% | 0.8% | ||
| Q2 24 | -52.5% | -4.7% | ||
| Q1 24 | -4.8% | 0.7% |
每股收益（稀释后）ATLNCCRN
| Q4 25 | $-0.48 | $-2.56 | ||
| Q3 25 | $-0.20 | $-0.15 | ||
| Q2 25 | $-0.20 | $-0.20 | ||
| Q1 25 | $-0.20 | $-0.02 | ||
| Q4 24 | $-1.37 | $-0.13 | ||
| Q3 24 | $-0.16 | $0.08 | ||
| Q2 24 | $-1.96 | $-0.47 | ||
| Q1 24 | $-0.19 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.1K | $108.7M |
| 总债务越低越好 | $84.7M | — |
| 股东权益账面价值 | $-32.1M | $322.8M |
| 总资产 | $113.2M | $449.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATLNCCRN
| Q4 25 | $81.1K | $108.7M | ||
| Q3 25 | $83.4K | $99.1M | ||
| Q2 25 | $374.7K | $81.2M | ||
| Q1 25 | $1.5M | $80.7M | ||
| Q4 24 | $678.7K | $81.6M | ||
| Q3 24 | $1.4M | $64.0M | ||
| Q2 24 | $439.5K | $69.6M | ||
| Q1 24 | $1.7M | $5.2M |
总债务ATLNCCRN
| Q4 25 | $84.7M | — | ||
| Q3 25 | $76.4M | — | ||
| Q2 25 | $75.4M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $80.6M | — | ||
| Q3 24 | $80.8M | — | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | — | — |
股东权益ATLNCCRN
| Q4 25 | $-32.1M | $322.8M | ||
| Q3 25 | $-22.1M | $408.1M | ||
| Q2 25 | $-18.5M | $412.2M | ||
| Q1 25 | $-14.0M | $418.2M | ||
| Q4 24 | $-12.0M | $419.0M | ||
| Q3 24 | $16.2M | $424.7M | ||
| Q2 24 | $23.0M | $433.3M | ||
| Q1 24 | $16.8M | $462.4M |
总资产ATLNCCRN
| Q4 25 | $113.2M | $449.0M | ||
| Q3 25 | $110.3M | $538.2M | ||
| Q2 25 | $106.8M | $553.8M | ||
| Q1 25 | $106.5M | $576.2M | ||
| Q4 24 | $119.8M | $589.3M | ||
| Q3 24 | $135.6M | $597.4M | ||
| Q2 24 | $134.2M | $602.9M | ||
| Q1 24 | $3.4M | $648.4M |
负债/权益比ATLNCCRN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.98× | — | ||
| Q2 24 | 3.41× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.2M | $18.2M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | $16.1M |
| 自由现金流率自由现金流/营收 | -6.8% | 6.8% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.5M | $40.1M |
8季度趋势，按日历期对齐
经营现金流ATLNCCRN
| Q4 25 | $-8.2M | $18.2M | ||
| Q3 25 | $-1.3M | $20.1M | ||
| Q2 25 | $-9.5M | $4.2M | ||
| Q1 25 | $14.6M | $5.7M | ||
| Q4 24 | $-426.3K | $24.2M | ||
| Q3 24 | $-1.3M | $7.5M | ||
| Q2 24 | $-15.5M | $82.4M | ||
| Q1 24 | $11.2M | $6.0M |
自由现金流ATLNCCRN
| Q4 25 | $-8.2M | $16.1M | ||
| Q3 25 | $-1.3M | $17.9M | ||
| Q2 25 | $-9.5M | $2.3M | ||
| Q1 25 | $14.6M | $3.8M | ||
| Q4 24 | $-449.4K | $21.7M | ||
| Q3 24 | $-1.4M | $6.3M | ||
| Q2 24 | $-15.5M | $79.6M | ||
| Q1 24 | $11.2M | $3.8M |
自由现金流率ATLNCCRN
| Q4 25 | -6.8% | 6.8% | ||
| Q3 25 | -1.2% | 7.2% | ||
| Q2 25 | -9.3% | 0.8% | ||
| Q1 25 | 14.2% | 1.3% | ||
| Q4 24 | -0.3% | 7.0% | ||
| Q3 24 | -1.3% | 2.0% | ||
| Q2 24 | -14.8% | 23.4% | ||
| Q1 24 | 11.2% | 1.0% |
资本支出强度ATLNCCRN
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 0.8% | ||
| Q1 24 | 0.0% | 0.6% |
现金转化率ATLNCCRN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATLN
暂无分部数据
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
